Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-09-29Clinical Trial Update: Sympathetic Renal Denervation Versus Increment of Pharmacological Treatment in Resistant Arterial Hypertension. [NA]
This clinical trial compared sympathetic renal denervation to uptitration of pharmacological therapy in resistant arterial hypertension and …
-
CLINICAL_TRIALS research · 2016-09-27Clinical Trial Update: Effect of Reminders on Adherence [NA]
A clinical trial update from the University of Pennsylvania describes a study evaluating whether reminders improve medication adherence in p…
-
FDA approval · 2016-09-26FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for a generic fixed-dose combination of irbesartan and hydrochlorothiazide from Aurobindo Pharma Lim…
-
FDA approval · 2016-09-23FDA Approved: NICARDIPINE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for nicardipine hydrochloride (Hikma Pharmaceuticals USA Inc.), resulting in labeling changes fo…
-
CLINICAL_TRIALS trial_result · 2016-09-23Clinical Trial Update: Target Organ Damage and Polymorphisms Vav-2 and Vav-3 in Hypertensive Subjects
This completed clinical trial explored whether target organ damage in hypertension is associated with polymorphisms in the Vav-2 and Vav-3 g…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-09-22FDA Approved: FUROSEMIDE — Supplemental Application (Hospira, Inc.)
FDA approves Hospira, Inc.'s supplemental application for furosemide, initiating a supplemental approval for the drug. The action updates th…
-
FDA approval · 2016-09-22FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for the Irbesartan and Hydrochlorothiazide combination by Macleods Pharmaceuticals Limited.
-
FDA approval · 2016-09-22FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Solco Healthcare US, LLC)
FDA approved a supplemental application for IRBESARTAN AND HYDROCHLOROTHIAZIDE, a fixed-dose combination for treating hypertension.
-
FDA approval · 2016-09-20FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for the fixed-dose combination irbesartan and hydrochlorothiazide (Teva). The product is used to tre…
-
FDA approval · 2016-09-19FDA Approved: FUROSEMIDE — Supplemental Application (Phlow Corporation)
FDA approved a supplemental application for furosemide submitted by Phlow Corporation.
-
FDA approval · 2016-09-19FDA Approved: SPIRONOLACTONE — Original Application (Accord Healthcare, Inc.)
FDA approves Accord Healthcare, Inc.'s original application for spironolactone (generic), authorizing its use as a potassium-sparing diureti…
-
FDA approval · 2016-09-16FDA Approved: VALSARTAN — Original Application (Macleods Pharmaceuticals Limited)
The FDA approved the original ANDA for valsartan from Macleods Pharmaceuticals Limited, making a generic ARB option available. This approval…
-
FDA approval · 2016-09-15FDA Approved: QUINAPRIL — Original Application (Solco Healthcare US, LLC)
FDA approves the original application for Quinapril, granting approval for a generic version manufactured by Solco Healthcare US, LLC.
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Assessing Blood Pressure Remotely in Childhood Cancer Survivors
Completed study evaluating remote blood pressure monitoring in childhood cancer survivors with hypertension.
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: TAPESTRY for People With Cardiovascular and Metabolic Disease: A Pilot Study [NA]
An update on the TAPESTRY pilot clinical trial for people with cardiovascular and metabolic disease, including diabetes mellitus and hyperte…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Mobile Phone in Hypertension Management [NA]
Göteborg University-led trial evaluating mobile phone-based management for hypertension has completed.
-
CLINICAL_TRIALS research · 2016-09-15Clinical Trial Update: Renal Denervation by Iberis MultiElectrode Renal Denervation System in Patients With Primary Hypertension [Phase 3]
Phase 3 clinical trial evaluating the Iberis MultiElectrode Renal Denervation System for primary hypertension; the current status of the stu…
-
CLINICAL_TRIALS trial_result · 2016-09-14Clinical Trial Update: Randomized Controlled Trial of Renal Denervation for Resistant Hypertension [Phase 3]
Phase 3 randomized trial evaluating renal denervation for resistant hypertension. The current status of the trial is unknown.
-
FDA approval · 2016-09-13FDA Approved: LISINOPRIL — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for lisinopril submitted by Aurobindo Pharma Limited under ANDA 077622.
-
CLINICAL_TRIALS trial_result · 2016-09-13Clinical Trial Update: Assessment of Volumetric Hemodynamic Parameters and Nutritional Status in Stable Renal Transplant Recipients
This is a completed clinical study assessing volumetric hemodynamic parameters and nutritional status in stable kidney transplant recipients…
-
CLINICAL_TRIALS trial_result · 2016-09-09Clinical Trial Update: L-arginine Treatment in Mild Hypertension [Phase 4]
Phase 4 clinical trial update on L-arginine for mild hypertension. The current status of the study is unknown.
-
FDA approval · 2016-09-08FDA Approved: LISINOPRIL — Supplemental Application (Solco healthcare U.S., LLC)
The FDA approved a supplemental application for lisinopril from Solco Healthcare U.S., LLC under an ANDA, confirming the approval of this ge…
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: A Trial of Telmisartan Prevention of Cardiovascular Disease [Phase 4]
A Phase 4 trial evaluating telmisartan for the prevention of cardiovascular disease has completed.
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: Causal Inference Research of Resistant Hypertension Treatment With Chinese Approach in a Cohort Study [EARLY_Phase 1]
A completed early-phase cohort study evaluating a Chinese approach to resistant hypertension using causal inference methods.
-
CLINICAL_TRIALS trial_result · 2016-09-05Clinical Trial Update: Effect of Renin-angiotensin System Blockers on Glomerular Filtration Rate in Patients With Hypertension, Type 2 Diabetes With Normoalbuminuria [Phase 4]
Phase 4 clinical trial update evaluating the effect of renin-angiotensin system blockers on glomerular filtration rate in adults with hypert…